Bell Investment Advisors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.7K | Buy |
1,219
+406
| +50% | +$4.58K | ﹤0.01% | 554 |
|
2025
Q1 | $8.2K | Sell |
813
-99
| -11% | -$999 | ﹤0.01% | 683 |
|
2024
Q4 | $10.8K | Buy |
912
+165
| +22% | +$1.95K | ﹤0.01% | 573 |
|
2024
Q3 | $8.62K | Buy |
747
+151
| +25% | +$1.74K | ﹤0.01% | 677 |
|
2024
Q2 | $6.3K | Hold |
596
| – | – | ﹤0.01% | 815 |
|
2024
Q1 | $6.28K | Hold |
596
| – | – | ﹤0.01% | 804 |
|
2023
Q4 | $6.69K | Buy |
596
+317
| +114% | +$3.56K | ﹤0.01% | 726 |
|
2023
Q3 | $3.26K | Sell |
279
-114
| -29% | -$1.33K | ﹤0.01% | 1035 |
|
2023
Q2 | $3.96K | Hold |
393
| – | – | ﹤0.01% | 940 |
|
2023
Q1 | $2.9K | Hold |
393
| – | – | ﹤0.01% | 1060 |
|
2022
Q4 | $3.14K | Buy |
+393
| New | +$3.14K | ﹤0.01% | 1046 |
|
2021
Q4 | $0 | Buy |
+48
| New | – | ﹤0.01% | 1920 |
|